Pittenger & Anderson Inc’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,415
Closed -$200K 436
2024
Q4
$200K Buy
+2,415
New +$190K 0.01% 221
2023
Q3
Sell
-93
Closed -$5.54K 440
2023
Q2
$5.54K Hold
93
﹤0.01% 391
2023
Q1
$5.27K Hold
93
﹤0.01% 384
2022
Q4
$6.91K Hold
93
﹤0.01% 361
2022
Q3
$6K Buy
93
+18
+24% +$1.08K ﹤0.01% 366
2022
Q2
$4K Buy
75
+2
+3% +$131 ﹤0.01% 388
2022
Q1
$5K Hold
73
﹤0.01% 381
2021
Q4
$5K Hold
73
﹤0.01% 393
2021
Q3
$6K Buy
73
+27
+59% +$2.17K ﹤0.01% 383
2021
Q2
$4K Hold
46
﹤0.01% 366
2021
Q1
$3K Buy
46
+8
+21% +$507 ﹤0.01% 363
2020
Q4
$2K Buy
38
+8
+27% +$460 ﹤0.01% 355
2020
Q3
$1K Buy
+30
New +$1.55K ﹤0.01% 356

Other funds holding GMED

Pittenger & Anderson Inc's GMED Position: Q1 2025 in Review

Pittenger & Anderson Inc sold out of Globus Medical (GMED) in Q1 2025, closing a stake of 2,415 shares — an estimated $200K sold.

Pittenger & Anderson Inc first reported a position in GMED in Q3 2020 and held it in 13 quarters. The position peaked at $200K in Q4 2024. 514 funds tracked by Wall St. Rank hold GMED as of Q1 2025.

  • Pittenger & Anderson Inc reported no remaining Globus Medical position as of Q1 2025 after selling out during the quarter.
  • Pittenger & Anderson Inc sold 2,415 Globus Medical shares in Q1 2025, an estimated $200K.
  • Pittenger & Anderson Inc first reported a position in Globus Medical in Q3 2020 and held it in 13 quarters.
  • Pittenger & Anderson Inc's Globus Medical position peaked at $200K in Q4 2024.
  • 514 funds tracked by Wall St. Rank held Globus Medical as of Q1 2025.

Based on Pittenger & Anderson Inc's 13F filing for Q1 2025, filed 1 May 2025.